IPP Bureau
Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment
By IPP Bureau - June 24, 2026
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
Teva study shows Huntington’s disease treatment improves life for patients & caregivers
By IPP Bureau - June 24, 2026
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Oval & Merck Specialities sign strategic pact to expand access to advanced IVF care in India
By IPP Bureau - June 24, 2026
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
By IPP Bureau - June 24, 2026
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
Govt seeks stakeholder feedback on proposed changes to GTE exemption list for medical devices
By IPP Bureau - June 24, 2026
Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry
Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
By IPP Bureau - June 24, 2026
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
By IPP Bureau - June 23, 2026
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
By IPP Bureau - June 23, 2026
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
By IPP Bureau - June 23, 2026
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
FDA advisory panel backs Moderna flu vaccine candidate for older adults
By IPP Bureau - June 23, 2026
The backing comes as influenza remains a persistent public health burden
FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
By IPP Bureau - June 23, 2026
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
By IPP Bureau - June 23, 2026
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
By IPP Bureau - June 23, 2026
Clearing 19 biologics for Europe market
ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
By IPP Bureau - June 23, 2026
The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows
HCG launches breast Cancer Care Clinic in Bengaluru
By IPP Bureau - June 23, 2026
About 250+ women riders participate in the awareness ride where free breast screening camp were conducted
